Login Register Cart 0
Generic placeholder image

Current Chromatography

Editor-in-Chief

ISSN (Print): 2213-2406
ISSN (Online): 2213-2414

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Sensitive UHPLC-MS/MS Technique for Monitoring Levothyroxine (T4) in Human Serum Against Endogenous Thyroxin Level

Author(s): Sanjay Kumar Yadav, Diwakar Pareek, Sanjeev Mishra, Sanjay Jagannath Gurule, Arshad Khuroo and Dipanjan Goswami*

Volume 9, Issue 1, 2022

Published on: 21 June, 2022

Article ID: e061221198572 Pages: 11

DOI: 10.2174/2213240608666211206095408

Price: $65

conference banner
Abstract

Background: Levothyroxine is a synthetic thyroid hormone that is chemically identical to Thyroxine (T4), which is secreted by the follicular cells of the thyroid gland. Levothyroxine is used to treat deficiency of thyroid hormone and prevent the recurrence of thyroid cancer. Levothyroxine is present endogenously in the human body.

Methods: It requires a treated matrix for the preparation of calibration curve standard and quality control samples. The method was developed using LC-MS/MS and validated in human charcoal stripped serum. Charcoal stripped matrix was used for the preparation of Calibration curve standards and Quality control samples. The method involves Solid-Phase Extraction technique. Levothyroxine D3 is used as an internal standard (ISTD).

Results: Chromatographic separation was achieved using reversed phase analytical column Gemini NX-C18 110Å, 3μm (50x3.6) mm. Mobile phase consisted of acetonitrile and water in a ratio of 70:30 with 150μL of formic acid in 1000 mL of the mobile phase. Mobile phase achieved shorter run-time of 0.9 minute due to the use of Ultra-high performance liquid chromatography (UHPLC). Positive electro-spray ionization technique detected MRM ion pair transitions 777.60→731.65 for Levothyroxine and 780.70→734.6 for Levothyroxine- D3 (ISTD) were used. AB SCIEX Triple Quad™ API-4000 LC-MS/MS system and the bioanalytical method with 10ng/mL as the limit of quantification have been applied successfully to pharmacokinetics studies.

Conclusion: Chromatographic separation was achieved using reversed phase analytical column Gemini NX-C18 110Å, 3μm (50x3.6) mm. Mobile phase consisted of acetonitrile and water in a ratio of 70:30 with 150μL of formic acid in 1000 mL of the mobile phase. Mobile phase achieved shorter run-time of 0.9 minutes due to the use of Ultra-high performance liquid chromatography (UHPLC). Positive electro-spray ionization technique detected MRM ion pair transitions 777.60→731.65 for Levothyroxine and 780.70→734.6 for Levothyroxine- D3 (ISTD). AB SCIEX Triple Quad™ API-4000 LC-MS/MS system and the bioanalytical method with 10ng/mL as the limit of quantification have been applied successfully to pharmacokinetics studies.

Keywords: Levothyroxine, serum, LC-MS/MS, validation, bioavailability studies, thyroid hormone.

[1]
Hays MT, Hsu L. Equilibrium dialysis studies of plasma binding of thyroxine, triiodothyronine and their glucuronide and sulfate conjugates in human and cat plasma. Endocr Res 1988; 14(1): 51-8.
[http://dx.doi.org/10.1080/07435808809036339] [PMID: 3391138]
[2]
Laessig RH, Hassemer DJ, Paskey TA, Schwartz TH. The effects of 0.1 and 1.0 per cent erythrocytes and hemolysis on serum chemistry values. Am J Clin Pathol 1976; 66(4): 639-44.
[http://dx.doi.org/10.1093/ajcp/66.4.639] [PMID: 970364]
[3]
Thienpont LM, De Brabandere VI, Stöckl D, De Leenheer AP. Development of a new method for the determination of thyroxine in serum based on isotope dilution gas chromatography mass spectrometry. Biol Mass Spectrom 1994; 23(8): 475-82.
[http://dx.doi.org/10.1002/bms.1200230804] [PMID: 7918690]
[4]
Siekmann L. Measurement of thyroxine in human serum by isotope dilution mass spectrometry. Definitive methods in clinical chemistry V Biomed Environ Mass Spectrom 1987; 14(11): 683-8.
[http://dx.doi.org/10.1002/bms.1200141120] [PMID: 2962677]
[5]
De Brabandere VI, Hou P, Stöckl D, Thienpont LM, De Leenheer AP. Isotope dilution-liquid chromatography/electrospray ionization-tandem mass spectrometry for the determination of serum thyroxine as a potential reference method. Rapid Commun Mass Spectrom 1998; 12(16): 1099-103.
[http://dx.doi.org/10.1002/(SICI)1097-0231(19980831)12:16<1099::AID-RCM290>3.0.CO;2-J] [PMID: 9737016]
[6]
Cooper DS. Treatment of Thyrotoxicosis. Werner and ingbar’s the thyroid:A fundamental and clinical text. (6th ed.). Philadelphia: JB Lippincott Co 1991; pp. 887-961.
[7]
Romanyshyn L, Tiller PR, Alvaro R, Pereira A, Hop CECA. Ultra-fast gradient vs. fast isocratic chromatography in bioanalytical quantification by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2001; 15(5): 313-9.
[http://dx.doi.org/10.1002/rcm.229] [PMID: 11241760]
[8]
Di Girolamo G, Keller GA, de Los Santos AR, Schere D, Gonzalez CD. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Clin Ther 2008; 30(11): 2015-23.
[http://dx.doi.org/10.1016/j.clinthera.2008.11.005] [PMID: 19108789]
[9]
Kiebooms JA, Wauters J, Vanden Bussche J, Vanhaecke L. Validated ultra high performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of total and free thyroid hormones in bovine serum. J Chromatogr A 2014; 1345(1345): 164-73.
[http://dx.doi.org/10.1016/j.chroma.2014.04.032] [PMID: 24786658]
[10]
U.S. Department of health and human services guideline for industry: bio-analyical method validation Food and Drug Administration (F.D.A.) Center for Drug Evaluation and Research (C.D.E.R.). 2018. Available from:https://www.fda.gov/media/70858/download(Accessed Jan 23, 2020).
[11]
Goswami D, Gurule S, Lahiry A, Anand A, Khuroo A, Monif T. Clinical development of imatinib: an anticancer drug. Future Sci OA 2016; 2(1): FSO92.
[http://dx.doi.org/10.4155/fso.15.92] [PMID: 28031942]
[12]
Goswami D, Gurule S, Singh P, et al. Method development challenges and regulatory expectation in Nifedipine. Int J Pharmacokinet 2017; 2(1): 21-37.
[http://dx.doi.org/10.4155/ipk-2016-0004]
[13]
Ruuskanen S, Hsu BY, Heinonen A, et al. A new method for measuring thyroid hormones using nano-LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1093-1094: 24-30.
[http://dx.doi.org/10.1016/j.jchromb.2018.06.052] [PMID: 29980100]
[14]
Rohit D, Chander MK, Manoj K, Kumar JG. Development and validation of UPLC-MS/MS Method for rapid simultaneous determination of levothyroxine and liothyronine in human serum. J Drug Deliv Ther 2020; 10(3-s): 176-81.
[http://dx.doi.org/10.22270/jddt.v10i3-s.4189]

Rights & Permissions Print Cite
Article Metrics
25
3
© 2024 Bentham Science Publishers | Privacy Policy